Introduction: What is Multidrug Resistance?

ABC Transporters and Multidrug Resistance

Volumn , Issue , 2009, Pages 1-13

  Sheps, Jonathan A ^a   Ling, Victor ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889485280     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470495131.ch     Document Type: Chapter

References (52)

1. Goldie JH and Coldman AJ. 1979. A mathematical model for relating the drug sensitivity of tumours to their spontaneous mutation rate. Cancer Treat Rep 63: 1727-1733.
2. Thompson L and Baker RM. 1973. Isolation of mutants in cultured mammalian cells. In Methods in Cell Biology, ed. DM Prescott, 209-281. New York: Academic Press.
3. Pommier Y, Pourquier P, Urasaki Y, Wu J, and Laco GS. 1999. Topoisomerase I inhibitors: Selectivity and cellular resistance. Drug Resist Updat 2: 307-318.
4. Austin CA and Marsh KL. 1998. Eukaryotic DNA topoisomerase IIβ. Bioessays 20: 215-226.
5. Pommier Y, Sordet O, Antony S, Hayward R, and Kohn KW. 2004. Apoptosis defects and chemotherapy resistance: Molecular maps and networks. Oncogene 23: 2934-2949.
6. Gottesman MM and Ling V. 2006. The molecular basis of multidrug resistance in cancer: The early years of P-glycoprotein research. FEBS Letters 580: 998-1009.
7. Ling V and Thompson LH. 1974. Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83: 103-106.
8. Danø K. 1973. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta-Biomembranes 323: 466-483.
9. Luria SE and Delbrück M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491-511.
10. Riordan JR and Ling V. 1979. Purification of P-glycoprotein from plasma mem-brance vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem 254: 12701-12705.
11. Ling V and Baker RM. 1978. Dominance of colchicine resistance in hybrid CHO cells. Somatic Cell Genet 4: 193-200.
12. Horio M, Gottesman MM, and Pastan I. 1988. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc Natl Acad Sci USA 85: 3580-3584.
13. Kartner N, Riordan JR, and Ling V. 1983. Cell surface P-glycoprotein is associated with multidrug resistance in mammalian cells. Science 221: 1285-1288.
14. Shapiro AB and Ling V. 1995. Reconstitution of drug transport by purified P-glycoprotein. JBiol Chem 270: 16167-16175.
15. Ling V. 1975. Drug resistance and membrane alteration in mutants of mammalian calls. Can J Genet Cytol 17: 503-515.
16. Carlsen SA, Till JE, and Ling V. 1976. Modulation of membrane drug permeability in Chinese hamster ovary cell mutants. Biochim et Biophys Acta 455: 900-912.
17. Tsuruo T, Iida H, Tsukagoshi S, and Sakurai Y. 1981. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972.
18. Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM et al. 1996. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 2: 1499-1508.
19. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, and Pastan I. 1987. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265-269.
20. Tatsuta T, Naito M, Oh-hara T, Sugawara I, and Tsuruo T. 1992. Functional involvement of P-glycoprotein in blood-brain barrier. J Biol Chem 267: 20383-20391.
21. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, and Melamed MR. 1990. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277-1287.
22. Galski H, Sullivan M, Willingham MC, Chin KV, Gottesman MM, Pastan I et al. 1989. Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: Resistance to daunomycin-induced leukopenia. Mol Cell Biol 9: 4357-4363.
23. Riordan JR, Rommens JM, Kerem B, Alog N, and Rozmahel R. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245: 1066-1073.
24. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC et al. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654.
25. Dean M, Rzhetsky A, and Allikmets R. 2001. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11: 1156-1166.
26. Roepe PD, Weisburg JH, Luz JG, Hoffman MM, and Wei LY. 1994. Novel Cl(-)-dependent intracellular pH regulation in murine MDR 1 transfectants and potential implications. Biochemistry 33: 11008-11015.
27. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R et al. 1993. The multidrug resistance (mdrl) gene product functions as an ATP channel. Proc Natl Acad Sci USA 90: 312-316.
28. Zhu BT. 1999. A novel hypothesis for the mechanism of action of P-glycoprotein as a multidrug transporter. Mol Carcinog 25: 1-13.
29. Eytan GD, Regev R, Oren G, and Assaraf YG. 1996. The role of passive transbilayer drug movement in multidrug resistance and its modulation. J Biol Chem 271: 12897-12902.
30. Van Bambeke F, Balzi E, and Tulkens PM. 2000. Antibiotic efflux pumps. Biochem Pharmacol 60: 457-470.
31. Korzekwa KR, Krishnamachary N, Shou M, Ogai A, Parise RA, Rettie AE et al. 1998. Evaluation of atypical cytochrome P450 kinetics with two-substrate models: Evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37: 4137-4147.
32. Seeling A. 1998. A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 251: 252-261.
33. Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Rothe J et al. 1998. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273: 10046-10050.
34. Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenbeiss J, Burchell B, and Keppler D. 1997. ATP-dependent transport of bilirubin glucoronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 327(Pt 1): 305-310.
35. Androlewicz MJ and Cresswell P. 1994. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1: 7-14.
36. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, and Kruh GD. 2002. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 62: 6172-6177.
37. Kino K, Taguchi Y, Yamada K, Komano T, and Ueda K. 1996. Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins. FEBS Lett 399: 29-32.
38. Sharom FJ, Lu P, Liu P, and Yu X. 1998. Linear and cyclic peptides as substrates and modulators of P-glycoprotein: Peptide binding and effects on drug transport and accumulation. Biochem J 333(Pt 3): 621-630.
39. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J et al. 2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775.
40. Higgins CF, Hiles ID, Salmond GP, Gill DR, Downie JA, Evans IJ et al. 1986. A family of related ATP-binding subunits coupled to many distinct biological processes in bacteria. Nature 323: 448-450.
41. Saurin W, Hofnung M, and Dassa E. 1999. Getting in or out: Early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J Mol Evol 48: 22-41.
42. Kerr ID. 2004. Sequence analysis of twin ATP biding cassette proteins involved in translational control, antibiotic resistance, and ribonuclease L inhibition. Biochem Biophys Res Commun 315: 166-173.
43. Zhou Z, White KA, Polissi A, Georgopoulos C, and Raetz CR. 1998. Function of Escherichia coli MsbA, an essential ABC family transporter, in lipid A and phospholipid biosynthesis. J Biol Chem 273: 12466-12475.
44. Binet R, Létoffé S, Ghigo JM, Delepelaire P, and Wandersman C. 1997. Protein secretion by Gram-negative bacterial ABC exporters-A review. Gene 192: 7-11.
45. Hui D and Ling V. 2002. A combinatorial approach toward analyzing functional elements of the Escherichia coli hemolysin signal sequence. Biochemistry 41: 5333-5339.
46. Zhang F, Sheps JA, and Ling V. 1993. Complementation of transport deficient mutants of E. coliα-hemolysin by second-site mutation in the transporter HlyB. J Biol Chem 268: 19889-19895.
47. Huynen MA and van Nimwegen E. 1998. The frequency distribution of gene family sizes in complete genomes. Mol Biol Evol 15: 583-589.
48. Sheps JA, Ralph S, Zhao Z-Y, Baillie DL, and Ling V. 2004. The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes. Genome Biol 5: R15.
49. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG. 1997. The ClustalX windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 24: 4876-4882.
50. Saitou N and Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
51. Swofford DL. 1997. Paup* (Phylogenetic analysis using parsimony and other methods). Various test versions. Sunderland, MA: Sinauer Associates.
52. Felsenstein J. 1985. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 39: 783-791.